Product Overview
The DRI® Cannabinoid Assay is intended for the qualitative and semi-quantitative determination of cannabinoids (THC) in human urine
Product Features
- Analyzers capable of maintaining a constant temperature, pipetting samples, mixing reagents, measuring enzymatic rates at 340 nm and timing the reaction accurately can be used to perform this assay
- Excellent correlation to GC/MS
Product Specifications
| Catalog Number/SKU | 5390012231 |
| Application | Toxicology Reagent |
|---|---|
| For Use With | For Clinical Chemistry Analyzers |
| Form | Ready-to-Use Liquid |
| Sample Type | Urine Sample |
| Specialty | Toxicology |
| Storage Requirements | Requires Refrigeration |
| Test Category | Drugs of Abuse |
| Test Method | Homogeneous Enzyme Immunoassay (HEIA) |
| Test Name | Cannabinoids (THC) |
| Test Type | Single Drug |
| Volume | 100 mL |
